SCHEMBL17488267

SCHEMBL17488267

Cn1c(NCc2ccc(Oc3ncc(Cl)cn3)cn2)nc2ccc(N)cc21

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.40
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KMT2A Q03164 1/20 0.37
PKM P14618 2/20 0.35
TP53 P04637 1/20 0.35
PDE2A O00408 1/20 0.34
DGAT2 Q96PD7 1/20 0.34
MCHR1 Q99705 1/20 0.34
LMNA P02545 1/20 0.33
P2RX3 P56373 1/20 0.33
KDR P35968 1/20 0.33
KDM4E B2RXH2 1/20 0.32
PPARG P37231 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18960431 0.90 NPC1 (0.43) CYP3A4NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL18960430 0.89 CYP3A4 (0.47) CYP3A4NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL18960426 0.88 NPC1 (0.48) CYP3A4NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL17488270 0.84 NPC1 (0.37) CYP3A4NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL18960449 0.84 GAA (0.42) NPC1RAB9ASMN1; SMN2KMT2APKM
SCHEMBL18960459 0.83 NPC1 (0.36) CYP3A4NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL17487724 0.81 CYP3A4 (0.35) CYP3A4NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL17488115 0.81 NPC1 (0.50) NPC1RAB9ASMN1; SMN2KMT2APKM
SCHEMBL18960456 0.80 NPC1 (0.42) CYP3A4NPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL17488133 0.80 NPC1 (0.49) CYP3A4NPC1RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016016421-A1 2-AMINO-BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS 5-LIPOXYGENASE AND/OR PROSTAGLANDIN E SYNTHASE INHIBITORS INSTITUT PASTEUR KOREA (KR) 2016-02-04 WO disclosed